Company intelligence / Profile preview

Kaisa Group Holdings Ltd.

Hong Kong, Hong Kong

Ownership: Private
Employees: ~17000
Development stage: Other

Overview

Kaisa Group is a diversified conglomerate primarily focused on property development, though it also operates in over 20 other industries including healthcare. The company has an investment in Zhenxing Biopharmaceutical, a blood product manufacturer, and has a history of debt restructuring and default on offshore bonds.

Industry: Investors

Partnerships

Zhenxing Group Co Ltd (investment in Zhenxing Biopharmaceutical)

Beyond the preview

Go deeper on Kaisa Group Holdings Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaisa Group Holdings Ltd..

Explore the full profile